Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gianpiero Rizzo

1PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

Pageof 1

Frequent Collaborators

1 joint publications

Marco Tagliamento

1 joint publications

Matteo Lambertini

1 joint publications

Ramon Salazar

1 joint publications

Nadia Harbeck

1 joint publications

Lucia Del Mastro

1 joint publications

Juan Aguilar-Company

1 joint publications

Mark Bower

1 joint publications

Alessia Dalla Pria

1 joint publications

Jasmine Handford

1 joint publications

Ailsa Sita-Lumsden

Frequent Collaborators

1 joint publications

Marco Tagliamento

1 joint publications

Matteo Lambertini

1 joint publications

Ramon Salazar

1 joint publications

Nadia Harbeck

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.1K
See more related videos

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.1K
See more related videos